GV1001 Telomerase peptide vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GV1001 Telomerase peptide vaccine, covering 2014-11-05 to 2014-11-05. Get the full timeline:
Most recent: Clinical Trial Update: Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma [Phase 1, Phase 2]